Evaluation of VX 445/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age
Clinical trial NCT03691779 · COMPLETED
Trial details
- NCT number
- NCT03691779
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-02
- Primary completion
- 2020-08-07
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.